Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingdi Zhao

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Immunotherapy|October 26, 2017
Autologous cytokine-induced killer cell immunotherapy may improve overall survival in advanced malignant melanoma patientsYong Zhang, Yu'nan Zhu, Erjiang Zhao, et al.
Journal of Clinical Apheresis|February 3, 2012
Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14-year experience of a single-center studyXiaohong Han, Li Ma, Lingdi Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 12, 2026
Multimodal Wearable Biosensing Meets Multidomain AI: A Pathway to Decentralized HealthcareChenshu Liu, Haolin Fan, Minwoo Kim, et al.
The Science of the Total Environment|October 29, 2020
Complete antigen-bridged DNA strand displacement amplification immuno-PCR assay for ultrasensitive detection of salbutamolLingdi Zhao, Huanying Zhou, Tieqiang Sun, et al.
Food Science & Nutrition|March 22, 2021
Simultaneous detection of diethylstilbestrol and estradiol residues with a single immunochromatographic assay stripZehua Xu, Tieqiang Sun, Hongwei He, et al.
Scientific Reports|August 7, 2025
Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapyYong Zhang, Chaoji Zhang, Peng Qin, et al.
Cancer Biology & Medicine|August 14, 2021
Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignanciesLu Han, Jian Zhou, Linlin Li, et al.
Journal for Immunotherapy of Cancer|August 15, 2020
Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virusLu Han, Jian Zhou, Keshu Zhou, et al.
Cancer Innovation|October 29, 2024
Combination therapy using low-dose anlotinib and immune checkpoint inhibitors for extensive-stage small cell lung cancerHan Li, Shumin Yuan, Han Wu, et al.
The Oncologist|March 29, 2022
Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory MelanomaShumin Yuan, Qiang Fu, Lingdi Zhao, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Immunotherapy|October 26, 2017
Autologous cytokine-induced killer cell immunotherapy may improve overall survival in advanced malignant melanoma patientsYong Zhang, Yu'nan Zhu, Erjiang Zhao, et al.
Journal of Clinical Apheresis|February 3, 2012
Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14-year experience of a single-center studyXiaohong Han, Li Ma, Lingdi Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 12, 2026
Multimodal Wearable Biosensing Meets Multidomain AI: A Pathway to Decentralized HealthcareChenshu Liu, Haolin Fan, Minwoo Kim, et al.
The Science of the Total Environment|October 29, 2020
Complete antigen-bridged DNA strand displacement amplification immuno-PCR assay for ultrasensitive detection of salbutamolLingdi Zhao, Huanying Zhou, Tieqiang Sun, et al.
Food Science & Nutrition|March 22, 2021
Simultaneous detection of diethylstilbestrol and estradiol residues with a single immunochromatographic assay stripZehua Xu, Tieqiang Sun, Hongwei He, et al.
Scientific Reports|August 7, 2025
Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapyYong Zhang, Chaoji Zhang, Peng Qin, et al.
Cancer Biology & Medicine|August 14, 2021
Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignanciesLu Han, Jian Zhou, Linlin Li, et al.
Journal for Immunotherapy of Cancer|August 15, 2020
Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virusLu Han, Jian Zhou, Keshu Zhou, et al.
Cancer Innovation|October 29, 2024
Combination therapy using low-dose anlotinib and immune checkpoint inhibitors for extensive-stage small cell lung cancerHan Li, Shumin Yuan, Han Wu, et al.
The Oncologist|March 29, 2022
Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory MelanomaShumin Yuan, Qiang Fu, Lingdi Zhao, et al.
Pageof 6